DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20203886

Safe pregnancy and delivery in COVID-19 time

Sakshi Agarwal

Abstract


The impact of COVID-19 on pregnant women is yet not defined. There is no clear evidence that they are more susceptible to COVID-19. Clinical features and diagnostic workup are similar as in non-pregnant women. This virus has been reported to cause complications like premature rupture of membranes, preterm birth and fetal distress in the last trimester but effects in first and second trimester are not apparent. This infection is a supportive indication for delivery if pregnant patient requires improvement in oxygen saturation. Treating doctor has to make individualized decision regarding mode of delivery considering maternal and fetal clinical conditions. Its vertical transmission from mother to baby and presence in breast milk and vaginal secretions has not been reported. So mother can feed breast milk to babies or it can be given in form of expressed milk. Further research and data collection are required for unanswered questions.


Keywords


Coronavirus, COVID-19, Delivery, Pregnancy

Full Text:

PDF

References


Siston AM, Rasmussen SA, Honein MA, Fry AM, Seib K, Callaghan WM, et al. PandemicH1N1 influenza in pregnancy working group. Pandemic 2009 influenza A (H1N1) virus illness among pregnant women in the United States. JAMA. 2010;303:1517-25.

Wong SF, Chow KM, Leung TN, Ng WF, Ng TK, Shek CC, et al. Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome. Am J Obstet Gynecol. 2004;191:292-7.

Alfaraj SH, Al-Tawfiq JA, Memish ZA. Middle East respiratory syndrome coronavirus (MERS-CoV) infection during pregnancy: report of two cases and review of the literature. J Microbiol Immunol Infect. 2019;52:501-3.

Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020;395:809-15.

Wang L, Shi Y, Xiao T, Fu J, Feng X, Mu D, et al. Chinese expert consensus on the perinatal and neonatal management for the prevention and control of the 2019 novel coronavirus infection (first edition). Ann Transl Med. 2010;8:47.

Liu D, Li L, Wu X, Zheng D, Wang J, Liang B, et al. Pregnancy and perinatal outcomes of women with COVID-19 pneumonia: a preliminary analysis. Am J Roentgenol. 2020;215:127-32.

Wang X, Zhou Z, Zhang J, Zhu F, Tang Y, Shen X. A case of 2019 novel coronavirus in a pregnant woman with preterm delivery. Clin Infect Dis. 2020;71(15):844-6.

Schwartz DA, Graham AL. Potential maternal and infant outcomes from coronavirus 2019-nCoV (SARS-CoV-2) infecting pregnant women: lessons from SARS, MERS, and other human coronavirus infections. Viruses. 2020;12:194.

Yang H, Wang C, Poon LC. Opinion. Novel coronavirus infection and pregnancy. Ultrasound Obstet Gynecol. 2020;55:435-7.

Rasmussen SA, Smulian JC, Lednicky JA, Wen TS, Jamieson DJ. Coronavirus disease 2019 (COVID-19) and pregnancy: what obstetricians need to know. Am J Obstet Gynecol. 2020;222(5):415-26.

Jenco M. Experts discuss COVID-19 impact on children, pregnant women; AAP News. Available at: https://www.aappublications.org/ news/2020/03/12/ coronavirus031220. Accessed on 05th May 2020.

Vivanti AJ, Deruelle P, Picone O, Guillaume S, Roze JC, Mulin B, et al. Follow-up for pregnant women during the COVID-19 pandemic: French national authority for health recommendations. J Gynecol Obstet Human Reprod. 2020:101804.

Poon LC, Yang H, Lee JC, Copel JA, Leung TY, Zhang Y, et al. ISUOG interim guidance on 2019 novel coronavirus infection during pregnancy and puerperium: information for healthcare professionals. Ultrasound Obstet Gynecol. 2020;55:700-8.

Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020;395:809-15.